Loading provider…
Loading provider…
Urology Physician in New York, NY
NPI: 1124004734Primary Employer
Mskcc Surgery Group
mskcc.org
HQ Phone
Get MD Harry's Phone Numberphone_androidMobile
Get MD Harry's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
NY State Medical License
1973 - 2027
CA State Medical License
1970 - 2023

American Board of Urology
Urology
New York Presbyterian Hospital (Cornell Campus)
Residency • Urology
1974 - 1976
University of California (Irvine)
Residency • Urology
1971 - 1974
Orange County Medical Center
Residency • Surgery
1970 - 1971
University of Southern California/LACUSC Medical Center
Internship • Transitional Year
1969 - 1970
UC Irvine School of Medicine
medschool.uci.edu
Medical School
Until 1969
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 52000Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | 129 | 165 |
Intermittent endocrine therapy for advanced prostate cancer.
Authors: Klotz, L H, Herr, H W, Morse, M J, Whitmore, W F
Journal: Cancer
Optimizing outcomes at every stage of bladder cancer: do we practice it?
Authors: Herr, Harry, Konety, Badrinath, Stein, John, Sternberg, Cora N, Wood, David P
Journal: Urol Oncol
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: Weill Medical College of Cornell University, New York Presbyterian Hospital
Intervention / Treatment: DRUG: Mitomycin C (MMC), BIOLOGICAL: Bacillus Calmette-Guerin (BCG)
Lead Sponsor: Ludwig Institute for Cancer Research
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: BIOLOGICAL: sargramostim, BIOLOGICAL: NY-ESO-1 protein, BIOLOGICAL: TICE®-strain BCG